Atlas Trials

A Study of Infusion Site Pain After Infusion of Excipients in Participants With Type 1 Diabetes Mellitus

Clinical trial NCT05067270 · COMPLETED

Trial details

NCT number
NCT05067270
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Type 1 Diabetes Mellitus
Start date
2021-10-22
Primary completion
2021-12-06
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.